What is the recommended dosing for Wellbutrin (bupropion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wellbutrin (Bupropion) Dosing

For depression, start bupropion SR at 150 mg once daily for 3 days, then increase to 150 mg twice daily (300 mg total daily); for smoking cessation, use the same titration schedule beginning 1-2 weeks before the quit date, with treatment lasting 7-12 weeks. 1, 2

Standard Dosing by Indication

Major Depressive Disorder

  • Initial dose: 150 mg once daily for 3 days 2
  • Maintenance dose: 150 mg twice daily (300 mg total daily) for SR formulation 2
  • XL formulation: Start 150 mg once daily, increase to 300 mg once daily as maintenance 2
  • Maximum dose: 400 mg/day for SR; 450 mg/day for XL 2, 3
  • The FDA-approved effective dose range is 300-450 mg/day, with the 450 mg dose showing superior efficacy in controlled trials 3

Smoking Cessation

  • Initiation timing: Begin 1-2 weeks before target quit date to establish therapeutic drug levels 1, 2
  • Days 1-3: 150 mg once daily 1, 2
  • Days 4 through end of treatment: 150 mg twice daily (300 mg total) if tolerated 1, 2
  • Maximum dose: 300 mg/day for smoking cessation 1, 2
  • Treatment duration: 7-12 weeks, with efficacy assessed at completion 1, 2
  • Therapy may be extended to 6 months-1 year to promote continued cessation 1

Timing of Administration

Take the first dose in the morning and the second dose (for SR formulation) before 3 PM to minimize insomnia risk. 2, 4

  • Morning dosing leverages bupropion's activating properties 2
  • Late-day dosing significantly increases insomnia risk, the most common side effect 2, 4, 5
  • XL formulation should be taken once daily in the morning only 2

Special Population Dosing

Older Adults (≥55 years)

  • Initial dose: 37.5 mg once daily in the morning 2, 4
  • Titration: Increase by 37.5 mg every 3 days as tolerated 2, 4
  • Maximum dose: 150 mg twice daily (300 mg total daily) 2, 4
  • Lower starting doses minimize adverse reactions in this population 2

Renal Impairment (GFR <90 mL/min)

  • Reduce total daily dose by half 2, 4
  • Bupropion and metabolites accumulate with renal dysfunction, requiring close monitoring for adverse reactions 2, 4, 3

Hepatic Impairment

  • Moderate to severe (Child-Pugh 7-15): Maximum 150 mg every other day 2, 3
  • Mild (Child-Pugh 5-6): Consider reducing dose and/or frequency 2, 3

Critical Safety Considerations

Absolute Contraindications

  • Seizure disorders or conditions lowering seizure threshold (stroke, brain metastases, eating disorders) 1, 2
  • Concurrent MAOI use or within 14 days of discontinuing MAOIs 1, 2
  • Bulimia or anorexia nervosa due to increased seizure risk 2, 4

Seizure Risk Minimization

  • Never exceed 300 mg/day for smoking cessation or 450 mg/day for depression 1, 2, 3
  • The seizure incidence is approximately 0.1% when dosing guidelines are followed 5, 6
  • Gradual titration is essential to minimize seizure risk while achieving therapeutic levels 2

Monitoring Requirements

  • Neuropsychiatric symptoms: Monitor for suicidal ideation (especially in patients <24 years), agitation, anxiety, mood changes 1, 4, 3
  • Blood pressure: Check at baseline and during titration; avoid in uncontrolled hypertension 2, 4
  • Drug interactions: Use caution with CYP2D6 inhibitors and avoid concurrent tamoxifen (reduces tamoxifen efficacy) 2, 4

Common Side Effects and Management

  • Insomnia (most common): Managed by ensuring second dose is before 3 PM 2, 4, 5
  • Dry mouth: Generally transient and resolves without intervention 5, 6
  • Nausea, headache, anxiety: Occur more frequently than placebo but are typically mild 5
  • Most side effects are transient and can be managed by dose reduction if necessary 5
  • Discontinuation rates due to adverse events are low (6-12%) in clinical trials 5

Clinical Pearls

  • Bupropion may be particularly beneficial for patients with comorbid depression and desire to quit smoking, addressing both conditions simultaneously 1, 2
  • The activating properties make it useful for patients with depression accompanied by apathy or low energy 2
  • If no response after 6-8 weeks at adequate dose, consider alternative treatment 2
  • Bupropion can be safely combined with NRT for smoking cessation with appropriate monitoring 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bupropion Initiation and Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.